Bellevue Life Sciences Ac...

NASDAQ: BLAC · Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-21.43 199.92 -2.58K -24.21K
PEG Ratio
0.03 -0.1 -2.95 279.37
PS Ratio
n/a n/a n/a n/a
PB Ratio
-7.97 2.48 -2.44K -37.78K
P/FCF Ratio
-23.62 -98.59 -21.6K -173.74K
P/OCF Ratio
-23.62 -98.59 -21.6K -173.74K
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
-0.27 n/a -31.99 -188.68
Quick Ratio
0.07 0.01 0.10 0.01
Current Ratio
0.07 0.01 0.10 0.01
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
81.96 n/a n/a n/a
Return on Equity
0.37 0.01 0.94 1.56
Return on Assets
-1.05 0.01 -0.03 n/a
Return on Invested Capital
1.14 -0.02 -0.03 -0.01
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a